DOI QR코드

DOI QR Code

Graves disease following rabbit antithymocyte globulin treatment of severe aplastic anemia in a Korean child

  • Choi, In Su (Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School) ;
  • Kim, Han Kyul (Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School) ;
  • Han, Dong Kyun (Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School) ;
  • Baek, Hee Jo (Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School) ;
  • Jang, Hae In (Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School) ;
  • Kim, Chan Jong (Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School) ;
  • Kook, Hoon (Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School)
  • 투고 : 2013.07.19
  • 심사 : 2013.11.26
  • 발행 : 2015.07.10

초록

Antithymocyte globulin (ATG) is used as an immunosuppressive treatment (IST) to deplete clonal suppressor T cells in patients with severe aplastic anemia (SAA). The depletion of suppressor T cells by ATG may affect the activation of B cells, which results in an increased risk for autoimmune conditions. A 12-year-old boy was diagnosed with idiopathic SAA. As he did not have an human leukocyte antigen-matched sibling, he was treated with rabbit ATG (3.5 mg/kg/day for 5 days) and cyclosporine. Five months later, he became transfusion independent. However, 23 months after IST, he complained of mild hand tremors, sweating, weight loss, palpitations, and goiter. Results of thyroid function tests revealed hyperthyroidism (free thyroxine, 3.42 ng/dL; thyroid stimulating hormone [TSH], <0.01 nIU/mL; triiodothyronine, 3.99 ng/mL). Results of tests for autoantibodies were positive for the antimicrosome antibody and TSH-binding inhibitory immunoglobulin, but negative for the antithyroglobulin antibody and antinuclear antibody. He was treated with methimazole, and his symptoms improved. The patient has been disease free for 39 months after IST and 9 months after methimazole treatment. This case report suggests that although rare, rabbit ATG may have implications in the pathogenesis of autoimmune hyperthyroidism. Our findings suggest that thyroid function tests should be incorporated in the routine follow-up of SAA patients treated with ATG.

키워드

참고문헌

  1. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006;108: 2509-19. https://doi.org/10.1182/blood-2006-03-010777
  2. Killick SB, Marsh JC, Gordon-Smith EC, Sorlin L, Gibson FM. Effects of antithymocyte globulin on bone marrow CD34+ cells in aplastic anaemia and myelodysplasia. Br J Haematol 2000;108: 582-91. https://doi.org/10.1046/j.1365-2141.2000.01853.x
  3. Teramura M, Kobayashi S, Iwabe K, Yoshinaga K, Mizoguchi H. Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism. Br J Haematol 1997;96:80-4. https://doi.org/10.1046/j.1365-2141.1997.d01-1981.x
  4. Todd A, Todd J. Graves' disease following successful treatment of severe aplastic anaemia with antilymphocyte globulin. Clin Lab Haematol 1999;21:69-70. https://doi.org/10.1046/j.1365-2257.1999.00190.x
  5. Zomas A, Marsh JC, Harrison NK, Hyer SL, Nussey SS, Knee G, et al. Rapid progression of fibrosing alveolitis and thyrotoxicosis after antithymocyte globulin therapy for aplastic anemia. Ann Hematol 1995;71:49-51. https://doi.org/10.1007/BF01696232
  6. Hinterberger-Fischer M, Kier P, Forstinger I, Lechner K, Kornek G, Breyer S, et al. Coincidence of severe aplastic anaemia with multiple sclerosis or thyroid disorders: report of 5 cases. Acta Haematol 1994;92:136-9. https://doi.org/10.1159/000204203
  7. Kumar M, Goldman J. Severe aplastic anaemia and Grave's disease in a paediatric patient. Br J Haematol 2002;118:327-9. https://doi.org/10.1046/j.1365-2141.2002.03581.x
  8. Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 2011;365:430-8. https://doi.org/10.1056/NEJMoa1103975
  9. Ginsberg J. Diagnosis and management of Graves’ disease. Can Med Assoc J 2003;168:575-85.
  10. Volpe R. The immunoregulatory disturbance in autoimmune thyroid disease. Autoimmunity 1988;2:55-72. https://doi.org/10.3109/08916938809019943
  11. Feng X, Kajigaya S, Solomou EE, Keyvanfar K, Xu X, Raghavachari N, et al. Rabbit ATG but not horse ATG promotes expansion of functional $CD4+CD25^{high}FOXP3+$ regulatory T cells in vitro. Blood 2008;111:3675-83. https://doi.org/10.1182/blood-2008-01-130146
  12. Scheinberg P, Fischer SH, Li L, Nunez O, Wu CO, Sloand EM, et al. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 2007;109:3219-24. https://doi.org/10.1182/blood-2006-09-045625
  13. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163-89. https://doi.org/10.1189/jlb.0603252
  14. Yoshikawa N, Mori S, Tokoro T, Ikehara S, Kumazawa H, Yamashita T, et al. IFN-gamma has a protective role against thyroid-specific autoantibody production in severe combined immunodeficient (SCID) mice xenografted with Graves' thyroid tissue. Thyroid 1996; 6:437-43. https://doi.org/10.1089/thy.1996.6.437
  15. Nishikawa T, Yamashita S, Namba H, Usa T, Tominaga T, Kimura H, et al. Interferon-gamma inhibition of human thyrotropin receptor gene expression. J Clin Endocrinol Metab 1993;77:1084-9.

피인용 문헌

  1. Graves’ disease following allogenic hematopoietic stem cell transplantation for severe aplastic anemia: case report and literature review vol.31, pp.5, 2015, https://doi.org/10.1515/jpem-2017-0358